Tag
Nureca Limited
8 articles
A significant shift in leadership and ownership is underway at Nureca Limited, potentially impacting the company’s strategic direction. Aryan Goyal is stepping down as CEO and director, while transferring his substantial stake to Saurabh Goyal, who will consolidate his control over the company. These changes are accompanied by a series of inter-se share transfers among promoter group entities, with Nectar Biopharma reducing its stake to zero. Despite these ownership adjustments, Nureca continues to expand its Dr Trust 360 connected health platform, recently surpassing 2.4 million users and launching an AI-powered analytics suite, suggesting a focus on digital health innovation even amidst internal restructuring.
Nureca Promoter Group Member Transfers Entire 12.15% Stake
Nureca Limited discloses off-market disposal of 1,159,185 equity shares (12.15% stake) by promoter group member Aryan Goyal.
Transfer executed via family settlement agreement dated 17 June 2026 as an
Nureca Promoter Group Sells 21.59% Stake
Disclosure under SEBI PIT Regulation 7(2) for an off-market disposal of equity shares by a promoter group member.
Payal Goyal transferred her entire 2,059,928 shares, representing a 21.59% stake, via
Nureca Promoter Saurabh Goyal Acquires 32.19 Lakh Shares
Nureca Limited discloses off-market acquisition of 32.19 lakh equity shares by promoter Saurabh Goyal via family settlement agreement.
The transaction, executed on July 2, 2026, increases Goyal's hold
Nureca CEO Aryan Goyal Resigns via Family Settlement
Nureca Limited CEO Aryan Goyal resigned effective July 1, 2026, citing a family settlement agreement as the reason.
His entire shareholding is being transferred to Saurabh Goyal concurrently with his
Nureca Limited Promoter Family Settlement Agreement
Nureca Limited discloses a Family Settlement Agreement executed on June 17, 2026 among promoter group members.
Under the agreement, Aryan Goyal and Payal Goyal will transfer their combined 33.74% stak
Nureca Promoter Group Inter-Se Share Transfer
Nureca Limited discloses an inter-se transfer of 60,842 equity shares among promoter group entities via off-market transaction.
Nectar Biopharma transferred shares to Saurabh Goyal, increasing his hol
Nureca Promoter Group Sells 60,842 Shares Off-Market
Nureca Limited discloses an off-market sale of 60,842 equity shares by promoter group entity Nectar Biopharma Private Limited.
The transaction, valued at ₹1.44 crore, reduced Nectar Biopharma's holdin
Nureca Promoter Saurabh Goyal Acquires 60,842 Shares
Nureca Limited discloses an off-market acquisition of 60,842 equity shares by promoter Saurabh Goyal on June 9, 2026.
The transaction increases Mr. Goyal's holding from 33.72% to 34.35% of the company